Drug
Dual Action Insulin Analog
Dual Action Insulin Analog: highest development phase Not Applicable, developed by Novo Nordisk. 1 trial record tracked on RxWires.
- Highest phase
- Not Applicable
- Developer
- Novo Nordisk
Trials
| Drug | Phase | Indication |
|---|---|---|
| dual-action insulin analog NCT00348231 | Not Applicable | Diabetes Mellitus, Type 2 |
Latest
No recent events.
Follow Dual Action Insulin Analog on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.